Dr. Matin has been a full professor at Stanford University for several years and is affiliated with several programs, including the Stanford Cancer Research Institute. He has contributed to many areas of biological research, e.g., bacterial infections and their treatment; discovery of new drugs and therapeutic enzymes and their improvement. He has pioneered mRNA-based gene delivery specifically to cancer using exosomes promising cure without side-effects – this approach is applicable to gene delivery-mediated treatment also of other diseases. He did his Ph. D. at UCLA, spent some years in the Netherlands (State University of Groningen), where he directed a research group, before joining Stanford. He is recipient of numerous awards and honors.
Dr. Kaiming Ye is Professor and Department Chair of Biomedical Engineering and Director of Center of Biomanufacturing for Regenerative Medicine at the Binghamton University (BU), State University of New York (SUNY). He is one of the top most distinguished and accomplished leaders in the field of Medical and Biological Engineering. He is fellow of AIMBE and senior member of IEEE. His scholarly contributions to the field include the development of the concept of advanced biomanufacturing and his leadership role in promoting and growing the field of the advanced biomanufacturing. He is well-known for his work in bioprinting and tissue biofabrication, in particular the biofabrication of human pancreatic islets from pluripotent stem cells such as iPSCs. His work in advanced biomanufacturing was featured as a cover story of ASEE PRISM journal. He has invented fluorescent nanosensors for continuous glucose monitoring for type-1 diabetic patients. His work in glucose sensors was featured in the Pittsburgh Post-Gazette. He invented recombinant yeast-based influenza vaccines. His current work includes the development of cancer immune therapeutic vaccines. His research has been continuously supported by NIH, NSF, JDRF, ABI and industries. He has chaired and co-chaired a number of international conferences and has delivered keynote/plenary speech in numerous international and national conferences. He co-organized more than 10 workshops, including two WTEC studies: “Global Assessment of Stem Cell Science and Engineering" and “Global Assessment of Advanced Biomanufacturing" to promote and grow the field of advanced biomanufacturing, He serves as Editor-in-Chief, Executive Editor, Associate Editor, and member of Editorial Boards of 13 journals. He is also a highly accomplished administrator and has contributed significantly to the national policy-make in science and engineering. During his tenure at NSF, he directed a biomedical engineering program, making funding decisions and implementing post-award management. He was member of a number of interagency working groups, including the Interagency Workgroup for Neuroscience, Interagency Modeling and Analysis Workgroup, and Multiagency Tissue Engineering and Regenerative Medicine Workgroup. In addition, he was involved in NSF CIF21 IGRET program, Cyber-Enabled Science and Engineering Program, NIH/NSF joint program on interface between physics and life science, and NIH/NCI-NSF Physicals and Engineering Sciences in Oncology program. Finally, he is a highly accomplished educator in biomedical engineering. As chair of Biomedical Engineering Department at BU, he led the growth of the Department.
Using cutting-edge technologies in molecular biology and plant genetics, my Sugarcane Breeding program at Texas A&M AgriLife Research has developed energy cane cultivars with high biomass yield, in partnership with Chevron Technologies Venture and BP Biofuels, that can be grown in a wider region of Texas and the United States, specifically designed for use in the production of bio-fuels. This program has also optimized efficient capabilities for scaling up production of feedstock planting stock. In addition, applying Next-Generation DNA sequencing techniques my program has identified and isolated genes controlling stress resistance, such as cold, which could prevent losses to the $3.8 billion US sugar industry and is developing DNA markers to tag important genes controlling cell wall composition and disease resistance.
Noriyoshi Sakai is Associate professor at National Institute of Genetics and the Graduate University for Advanced Studies, SOKENDAI, in Japan, received his Ph. D. from Kanazawa University. Following postdoctoral training in hormonal regulation of fish germ cell development with Yoshitaka Nagahama at National Institute for Basic Biology, he joined the faculty at Fukui Prefectural University. He started the study of spermatogenesis in zebrafish in Nancy Hopkins’ Lab at Massachusetts Institute of Technology as a visiting scientist, and moved to National Institute of Genetics. He has contributed in several aspects of gametogenesis in fish, e.g., steroid hormonal regulation and molecular mechanisms of germ cell development and genetic modification of germ cells. He has pioneered culture of germ cells that represents the entire spermatogenesis process, from stem cell propagation to differentiation of functional sperm. Furthermore, he has established a novel transplantation method using immunodeficient mutant zebrafish for germline stem cells and living whole embryos that can support their development.
Yongjun Liu, MD, Ph.D., is currently a physician pathologist in the School of Medicine and Public Health at the University of Wisconsin – Madison. He earned his Ph.D. in the field of Human Genetics at Creighton University. He completed his pathology residency training in pathology at Penn State Hershey Medical Center and clinical fellowship in gastrointestinal, hepatic, and pancreatobiliary pathology at the University of Washington School of Medicine. His expertise is in the field of clinical, pathological, genetic/genomic studies of human complex diseases including hepatocellular carcinoma, cholangiocarcinoma, pancreatic carcinoma, inflammatory bowel disease, obesity, osteoporosis, and other related human diseases. He has published more than 100 peer-reviewed articles and book chapters.
Douglas McCloskey obtained his PhD in 2017 in bioengineering in the lab of Bernhard O. Palsson at the University of California, San Diego. During his studies, he was awarded the prestigious Siebel’s Scholars Foundation grant. Douglas McCloskey is currently a group leader at the Novo Nordisk Foundation Center for Biosustainability (CfB) at the Technical University of Denmark. At the CfB, He is leading a group of automation engineers, software engineers, and analytical chemists to develop Big –Omics data generation workflows and leading a group of PhDs and Postdocs to develop advanced machine learning and biochemical modeling algorithms to learn from Big –Omics data.
After earning B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi, and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj, Dr. Dhruv Kumar completed his Ph.D. in Cellular, Molecular and Industrial Biology from theUniversity of Bologna (UNIBO), Italy under one of the prestigious fellowships of Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. After completion of his Ph.D., he received five years of Postdoctoral training from the School of Medicine, University of Kansas Medical Center, Kansas City, USA. Currently, he is working as a Professor of Cancer Biology and Molecular Medicine at Amity Institute of Molecular Medicine and Stem Cell Research. He has worked on several cancers, including Prostate, Pancreatic, Brain, Breast, and Head and Neck Cancer focusing on understanding the molecular mechanism (s) of the regulation of autophagy and Apoptosis in Cancer Stem Cells (Prostate, Pancreatic, Brain, and Breast). Specifically, he studied the molecular mechanism (s) of induced Autophagy in Cancer Stem Cells (CSCs) via PI3K/Akt/mTOR signaling pathway's and molecular cross-talk between the tumor microenvironment (CancerAssociated Fibroblast (CAF)) and Head and Neck Squamous Cell Carcinoma (HNSCC) via HGF/c-MET and FGF/FGFR signaling pathways, intra-tumor mutational heterogeneity. Currently, his lab is exploring the Autophagy-Metabolic axis in cancer cells (head and neck, oral, breast, and brain) and tumor microenvironment for the development of a therapeutic approach. Recently, his group has significantly contributed to Drug Designing and Drug Repurposing for COVID-19. Apart from his research, he has actively involved in teaching courses at UG, PG, and Ph.D. levels related to Cancer Biology, Stem Cell Biology, Molecular Medicine, and Bioinformatics.
Professor and Head (Retired) of the School of Biotechnology at Devi Ahilya University (DAVV), Indore, India from June 20, 1991 to December 31, 2018 (up to the last day of retirement). Procured doctorate degree (Ph.D.) in biochemistry in 1983. In 1985, joined Prof. Jack Preiss lab at the Michigan State University, East Lansing, USA as a visiting research associate. After three years of hard work, returned to India with a sole intention to serve the birth country. Since 1988, constantly working in teaching, research, and administrative domains and serving the nation. Areas of expertise are enzyme technology, molecular biology, and genetic engineering. An internationally acclaimed scientist with more than 180 full-length research papers, 13 books, and 32 chapters in various edited books. Successfully guided nearly 30 Ph.D. students. Foremost scientist to deduce the amino acid sequence of glycogen synthase, a study published in J. Biol. Chem. in 1986 and the work was humbly dedicated to Dr. Luis F. Leloir on the occasion of his 80th birthday. Authored books are published by various national and international publishers, such as Horizon Scientific Press (UK), Nova Science Publishers (USA), Anamaya Publishers (India), MV Learning (UK), Viva Books Pvt Ltd. (India), etc. Authored number of chapters for many books, including Encyclopedia of Molecular Cell Biology & Molecular Medicine, which has an editorial board comprising 14 members, 10 of which are Nobel laureates. In 2012, the chapter on Regulation of Gene Expression was published in Epigenetic Regulation and Epigenomics (a two-volume series from Wiley VCH). An updated version of the same chapter was published in RNA Regulation from Wiley VCH itself in 2014. This chapter was again published in Synthetic Biology- Advances in Molecular Biology and Medicine (Ed. Robert A Meyers, Wiley- VCH) in 2015. Fellow of many societies, including World Society of Cellular & Molecular Biology, France where 21 of the colleague fellows are Noble laureates. Editor-in-chief of the Canadian Journal of Biotechnology. Associate Editor of the Journal of Cell & Tissue Research. Member of the Editorial Board of many journals, such as Journal of Proteomics & Bioinformatics, Journal of Computer Science & Systems Biology, Current Trends in Biotechnology and Pharmacy, Biotechnology & Molecular Biology Reviews, Nano Biomedicine and Engineering, British Biotechnology Journal, etc. Honorary Advisor of HS Counseling, Canada. Presented research work at a number of International Conferences. Hosted and chaired a symposium at the 4th World Congress of Cellular & Molecular Biology held at Poitiers, France in 2005. Hosted and organized 5th World Congress of Cellular & Molecular Biology (November 02–06, 2009) & was the Congress President. The research laboratory is of international standards where students of different origins conduct their research work. Although the lab specializes in enzyme technology, the students work in many diversified areas. Apart from the teaching and research, have immense administrative experience and equipped with leadership skills. Worked as an acting Vice-Chancellor of DAVV numerous times. Founder member of the School of Biotechnology at DAVV. Served as the head of the entire department from 1991 to 2018. Served as an officer-in-charge of the Bioinformatics Sub Center, DAVV from 1993 to 2018. Served as a director of International Institute of Professional Studies at DAVV in 2004. Appointed as a chairman of several university committees.